Introduction:

Keratoendotheliitis Fugax Hereditaria (KEFH) is a rare and inherited corneal disorder characterized by recurrent episodes of transient corneal edema and inflammation. This article provides an in-depth overview of KEFH, including its clinical presentation, etiology, diagnostic approach, management options, and genetic implications.

Clinical Presentation:

KEFH typically presents in the first or second decade of life and is often characterized by episodes of sudden, unilateral corneal edema accompanied by mild to moderate eye pain and decreased visual acuity. These episodes are transient and tend to resolve spontaneously within hours to a few days, leaving no residual corneal scarring. The frequency and severity of the episodes can vary among affected individuals.

Etiology:

KEFH is believed to have an autosomal dominant inheritance pattern, meaning that a child has a 50% chance of inheriting the condition if one parent is affected. Mutations in the COL8A2 gene, which encodes for collagen type VIII alpha 2 chain, have been identified as the underlying genetic cause of KEFH. This mutation leads to alterations in the corneal endothelial cells' function, resulting in episodes of corneal edema.

Diagnostic Approach:

A comprehensive evaluation is essential to diagnose KEFH accurately. Ophthalmologists may perform various tests, including slit-lamp biomicroscopy, to assess corneal edema and any associated inflammatory signs. Specular microscopy is useful for visualizing corneal endothelial cells and detecting any morphological changes. Genetic testing may also be employed to confirm the presence of mutations in the COL8A2 gene.

Management Options:

Currently, there is no definitive cure for KEFH. Management focuses on alleviating symptoms and reducing the frequency and severity of the episodes. Topical hypertonic saline drops can help reduce corneal edema during acute episodes. The use of topical corticosteroids may be considered to manage inflammation and discomfort. In severe and refractory cases, endothelial keratoplasty (DSEK or DMEK) may be indicated to improve corneal function and vision.

Genetic Implications:

As KEFH is an inherited condition, genetic counseling is crucial for affected individuals and their families. Identifying the specific COL8A2 gene mutation can help with family planning and early detection of the condition in at-risk relatives. Genetic counseling can also provide information on the risk of passing the condition to future generations and potential implications for affected individuals' offspring.

Conclusion:

Keratoendotheliitis Fugax Hereditaria (KEFH) is a rare inherited corneal disorder characterized by recurrent episodes of transient corneal edema and inflammation. Early diagnosis, genetic testing, and proper management are essential in improving the quality of life for affected individuals and providing appropriate counseling for their families.

Hashtags: #KEFH #CornealDisorder #CornealEdema #Inflammation #VisualAcuity #AutosomalDominant #COL8A2Gene #CornealEndothelialCells #SpecularMicroscopy #SlitLampBiomicroscopy #GeneticTesting #HypertonicSalineDrops #TopicalCorticosteroids #EndothelialKeratoplasty #DSEK #DMEK #GeneticCounseling #FamilyPlanning #Ophthalmologist